About Fukuoka Tokushukai Hospital
Clinical Trials at Fukuoka Tokushukai Hospital
During the past decade, Fukuoka Tokushukai Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 9 clinical trials were completed, i.e. on
average, 90% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Fukuoka Tokushukai Hospital" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Pfizer" with 4 trials
sponsored, "Bayer" with 2 trials sponsored, "Arena Pharmaceuticals" with 1 trials sponsored and "Boston Scientific Corporation"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Fukuoka Tokushukai Hospital"
#1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "ICON Clinical Research" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Fukuoka Tokushukai Hospital
According to Clinical.Site data, the most researched conditions in "Fukuoka Tokushukai Hospital" are
"Hemorrhage" (2 trials), "Stroke" (2 trials), "Ulcerative Colitis" (2 trials), "Acute Myocardial Infarction" (1 trials) and "Acute Pain in Herpes Zoster" (1 trials). Many other conditions were trialed in "Fukuoka Tokushukai Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Fukuoka Tokushukai Hospital
Most popular intervention types in "Fukuoka Tokushukai Hospital" are "Drug" (9 trials), "Other" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Etrasimod" (2 trials), "idarucizumab" (2 trials), "ASA 100 mg" (1 trials) and "BAY2433334" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Fukuoka Tokushukai Hospital
The vast majority of trials in "Fukuoka Tokushukai Hospital" are
13 trials for "All" genders.
Clinical Trials Status at Fukuoka Tokushukai Hospital
Currently, there are NaN active trials in "Fukuoka Tokushukai Hospital".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in Fukuoka Tokushukai Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Fukuoka Tokushukai Hospital, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".